By Memorial Sloan Kettering | Monday, May 7, 2012
Dr. Jarnagin – a surgeon who treats patients with disorders of the pancreas, liver, and bile ducts – discusses the specialized expertise of surgeons at Memorial Sloan Kettering, a high-volume center.
By Memorial Sloan Kettering | Thursday, May 3, 2012
Dr. Rusch, Chief of the Thoracic Service, discusses the multidisciplinary care plan that is developed for each patient by a specialized team of physicians at Memorial Sloan Kettering.
By Memorial Sloan Kettering | Friday, April 27, 2012
Dr. Van Zee discusses the personalized care delivered by a multidisciplinary team of breast cancer experts at Memorial Sloan Kettering.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Wednesday, April 25, 2012
Researchers have demonstrated a technique that enables specific and accurate labeling of brain tumor tissue in mice. If proven effective in patients, the method could make complete surgical removal of brain tumors more feasible.
By Memorial Sloan Kettering | Monday, April 23, 2012
Patty grew up playing in the sun at the beach, so when she developed a growth under her eye she knew it could be skin cancer. Experts at Memorial Sloan Kettering Basking Ridge diagnosed her with basal cell carcinoma and performed a highly specialized surgery to remove the cancer.
By Memorial Sloan Kettering | Monday, April 16, 2012
James Eastham, Chief of Memorial Sloan Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.
By Memorial Sloan Kettering | Monday, April 9, 2012
A routine blood test led to a diagnosis of bone cancer for Bruce, an otherwise healthy 43-year-old writer. Surgeons at Memorial Sloan Kettering removed his cancer and saved his leg, giving him the chance to resume his career as “the writer who walks.”
By Memorial Sloan Kettering | Thursday, April 5, 2012
Yuman Fong, Memorial Sloan Kettering’s Vice Chair of Technology Development and a surgeon who treats patients with liver, bile duct, gallbladder, and pancreas diseases, talks about surgical advances that improve outcomes for patients.
In the O.R.
By Esther Napolitano, BS and Allyson Collins, MS
Friday, March 16, 2012
Memorial Sloan Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove small breast cancers.
By Memorial Sloan Kettering | Monday, March 12, 2012
Department of Surgery Chair Peter T. Scardino reflects on the expanding role of surgery at an institution devoted to caring for people with cancer.
By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, January 31, 2012
Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.
By Memorial Sloan Kettering | Monday, January 30, 2012
While a diagnosis of cervical cancer once required a hysterectomy, a procedure called a radical trachelectomy eliminated Stephanie Luedke’s cancer and preserved her ability to bear a child.
By Memorial Sloan Kettering | Thursday, January 19, 2012
When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.
By Memorial Sloan Kettering | Tuesday, January 17, 2012
The Spine Tumor Center at Memorial Sloan Kettering provides state-of-the-art diagnostic and treatment services for more than 1,500 people with primary or metastatic spine tumors each year.
By Memorial Sloan Kettering | Wednesday, December 21, 2011
As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.